G.E.N.E.S.I.S. / Directives / DIR-B8-S15-5V1H

DIR-B8-S15-5V1H

Package NASA Medical Robotics Regulatory Checklist via Data Compilation

85% confidenceOPEN
https://technology.nasa.gov/MSC-TOPS-45

Organization

NASA Robonaut 2 Technology Portfolio (TRL 6)

Sector

Medical device regulatory consultants and startup CTOs

Location

Location unspecified

Budget

$4,850-$9,700 from 50-100 checklist sales at $97 each

Required AuthorityAUTHORITYThe internal metric of trust, execution capacity, and network gravity within GENESIS. Higher Authority grants access to increasingly sensitive, high-yield Directives. Authority is distinct from, and independent of, any federal, state, or corporate security clearance.

II: Operative

Posted

Apr 09, 2026

Intel / Context Summary

NASA holds nearly 50 patented and patent-pending technologies from the Robonaut 2 program specifically positioned for medical applications, with established licensing infrastructure but zero documented market demand signals. The agency has supply-side readiness through its Technology Transfer Program but lacks commercial validation and market pull evidence.

Catalyst: Why Now

NASA states 'commercial products must meet relevant medical device regulatory standards' but provides zero guidance on which FDA classifications apply to which Robonaut 2 components, creating confusion and research overhead for potential licensees.

Friction: The Bottleneck

  • Vulnerability: NASA states 'commercial products must meet relevant medical device regulatory standards' but provides zero guidance on which FDA classifications apply to which Robonaut 2 components, creating confusion and research overhead for potential licensees.
  • Capital yield: $4,850-$9,700 from 50-100 checklist sales at $97 each
  • Resource capture: Proprietary FDA classification mapping for NASA robotics components
  • Influence capture: Authority position as the go-to expert on space robotics regulatory pathways
  • Required vectors: Vector: FDA Regulatory Research, Vector: Technical Documentation, Vector: B2B Micro-Sales

Wedge: Execution Protocol

Phase 1: Map Robonaut 2 Components to FDA Classifications: Scrape the MSC-TOPS-45 technology page for all component descriptions. Research FDA 510(k) database for similar robotic surgical devices and their classifications. Cross-reference with FDA guidance documents for 'computer-assisted surgical devices' and 'robotic surgery systems'. Create mapping: 'Robonaut 2 Force Sensor → likely Class II, product code OLO', 'Robonaut 2 Vision System → likely Class II, product code NAY', etc. → Phase 2: Create 'NASA Medical Robotics FDA Navigator' Checklist: Format the mapping into a clean, branded PDF checklist. Include: (1) Component-by-component classification guide, (2) Estimated 510(k) submission timeline for each component, (3) List of FDA-recognized standards that apply (IEC 60601-1, etc.), (4) Template email to FDA for pre-submission meeting. Design professional cover and table of contents. → Phase 3: Distribute via Targeted Outreach and Micro-Sales: Scrape LinkedIn for medical device regulatory consultants and startup CTOs in surgical robotics (500+ profiles). Send cold LinkedIn messages: 'I mapped the FDA pathway for NASA's Robonaut 2 medical technologies — sending you the checklist.' Include link to Gumroad page selling the checklist for $97. Follow up with email sequence.

Specific Roles Required

Vector: FDA Regulatory Research

Primary executor: Phase 1: Map Robonaut 2 Components to FDA Classifications: Scrape the MSC-TOPS-45 technology page for all component desc

Vector: Technical Documentation

Supporting vector for: Package NASA Medical Robotics Regulatory Checklist via Data Compilation

Vector: B2B Micro-Sales

Supporting vector for: Package NASA Medical Robotics Regulatory Checklist via Data Compilation

Claim Protocol

Sign in to begin the claim protocol.

Sign In
← Return to Board